Skip to main content
Premium Trial:

Request an Annual Quote

Aptus Genomics Announces $6.2 Million in Funding

NEW YORK, May 14 – Aptus Genomics added $6.2 million to its coffers in its latest round of financing, the Rockville, Maryland-based company announced Monday.

The funding came from Emerging Technology Partners, The Grosvenor Funds, and VitalBio. 

Aptus develops technology platforms to discover and analyze the function of selected families of human genes. The company, founded in June 2000, has stated it is initially concentrating its efforts on cell surface receptors. The latest round of funding will be used in R&D, staffing and general expenses, according to the company.

"Aptus’ focus on research enablement through gene discovery, qualification, and utilization will allow biotech and pharmaceutical companies, as well as Aptus’ own researchers, to accelerate drug discovery," Wei-Wu He of Emerging Technology Partners said in a statement. He is also Aptus’ Chairman of the Board.

 

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.